Andrey Zarur
CEO

GreenLight Biosciences produces RNA‑interference (RNAi) biopesticides that silence target genes in insects, fungi, and weeds, delivering species‑level specificity with rapid environmental degradation and no residue on crops. Their scalable manufacturing platform creates commercial‑grade foliar sprays compatible with standard farm equipment, offering growers a residue‑free, EPA‑approved alternative to conventional chemicals.
Funding not disclosed





+2CEO
CEO
Conventional chemical pesticides increasingly face regulatory restrictions, consumer backlash, and resistance development, limiting their effectiveness and raising environmental concerns for growers. Farmers lack scalable, residue‑free alternatives that can protect crops while preserving beneficial organisms such as pollinators.
GreenLight Biosciences delivers RNA‑interference (RNAi) biopesticides that target specific insect, fungal, or weed genes, providing a biologically precise mode of action. Their proprietary production platform synthesizes complex RNA molecules at competitive cost and scale, enabling commercial‑grade foliar applications. Products such as Calantha, an EPA‑approved RNAi insecticide for Colorado potato beetle, demonstrate efficacy comparable to synthetic chemicals while degrading rapidly in soil and water, leaving no detectable residue. The technology’s selectivity spares non‑target species, supporting integrated pest‑management and resistance‑rotation programs. By replacing hazardous chemicals with biodegradable RNA solutions, GreenLight offers growers a sustainable tool that aligns with ESG objectives and regulatory trends.
Primary customers are commercial growers and agribusinesses—such as potato, fruit, and vegetable producers—seeking effective, residue‑free pest control solutions that meet regulatory and sustainability requirements.